Khadim India Q1FY27 Results: Board Approves Unaudited Standalone & Consolidated Financial Results
Khadim India Limited announced its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The Board also approved the issuance of 10,22,727 convertible warrants to promoters and non-promoters, subject to stock exchange approval. The warrants are convertible into equity shares at ₹110 each.
The approval of quarterly financial results is a standard disclosure. However, the approval of convertible warrants for fundraising has a potential medium-term impact on the company's capital structure and future operations, pending regulatory approvals.
The announcement primarily reports financial results and a corporate action (warrant issuance), which are routine for a listed company. While the results themselves are not detailed in this snippet, the overall tone is factual and informative, without strong positive or negative indicators.
Khadim India Limited announced the outcome of its Board Meeting held on August 07, 2026. The Board of Directors considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
The financial results were reviewed and recommended by the Audit Committee. The detailed Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report issued by M/s. Ray & Ray (Chartered Accountants), Statutory Auditors, have been enclosed and will be available on the company's website, www.khadims.com, as well as on the websites of the BSE and NSE.
The Board Meeting commenced at 2:00 p.m. and concluded at 4:15 p.m. The company's registered office is located at RDB Primarc TechPark, Tower - C, 7th floor, 08 Major Arterial Road, Block - AF, New Town (Rajarhat), Kolkata - 700 156.
Additionally, the announcement details the approval by the members of the company via an Extra-Ordinary General Meeting held on August 01, 2026, for the issuance of 10,22,727 fully convertible Equity Share Warrants. These warrants are exercisable at ₹110/- per underlying Equity Share, with a premium of ₹100/- per share, convertible into one Equity Share of face value ₹10/- each, at a premium of ₹100/- per share. The total issue size is up to ₹112.50 million in cash to Promoter and Non-Promoter Category. However, final approval from stock exchanges is pending. The warrants will be allotted within 15 days of receiving stock exchange approval, with 25% of the issue price payable upfront. The balance 75% of the exercise price can be paid within a period of eight months from the date of allotment of warrants.
What to do with a filing like this
Khadim India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Khadim India Limited. Read the original for the full detail.